Tilray (TLRY) Competitors $1.20 +0.02 (+1.69%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TLRY vs. CRON, USNA, MNMD, CDXC, BTMD, SNDL, CGC, ACB, MDWD, and FTLFShould you be buying Tilray stock or one of its competitors? The main competitors of Tilray include Cronos Group (CRON), USANA Health Sciences (USNA), Mind Medicine (MindMed) (MNMD), ChromaDex (CDXC), biote (BTMD), SNDL (SNDL), Canopy Growth (CGC), Aurora Cannabis (ACB), MediWound (MDWD), and FitLife Brands (FTLF). These companies are all part of the "medicinals & botanicals" industry. Tilray vs. Cronos Group USANA Health Sciences Mind Medicine (MindMed) ChromaDex biote SNDL Canopy Growth Aurora Cannabis MediWound FitLife Brands Cronos Group (NASDAQ:CRON) and Tilray (NASDAQ:TLRY) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk, community ranking and dividends. Which has better valuation and earnings, CRON or TLRY? Cronos Group has higher earnings, but lower revenue than Tilray. Cronos Group is trading at a lower price-to-earnings ratio than Tilray, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCronos Group$111.23M6.84-$73.96M-$0.13-15.31Tilray$788.94M1.37-$244.98M-$0.30-4.00 Do insiders & institutionals hold more shares of CRON or TLRY? 8.7% of Cronos Group shares are held by institutional investors. Comparatively, 9.4% of Tilray shares are held by institutional investors. 6.9% of Cronos Group shares are held by insiders. Comparatively, 0.9% of Tilray shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community favor CRON or TLRY? Cronos Group received 16 more outperform votes than Tilray when rated by MarketBeat users. Likewise, 61.13% of users gave Cronos Group an outperform vote while only 59.26% of users gave Tilray an outperform vote. CompanyUnderperformOutperformCronos GroupOutperform Votes46461.13% Underperform Votes29538.87% TilrayOutperform Votes44859.26% Underperform Votes30840.74% Is CRON or TLRY more profitable? Tilray has a net margin of -26.79% compared to Cronos Group's net margin of -42.65%. Tilray's return on equity of -2.00% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets Cronos Group-42.65% -2.56% -2.47% Tilray -26.79%-2.00%-1.60% Do analysts rate CRON or TLRY? Cronos Group currently has a consensus target price of $3.00, indicating a potential upside of 50.75%. Tilray has a consensus target price of $2.70, indicating a potential upside of 125.00%. Given Tilray's stronger consensus rating and higher possible upside, analysts clearly believe Tilray is more favorable than Cronos Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Tilray 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40 Which has more risk and volatility, CRON or TLRY? Cronos Group has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Comparatively, Tilray has a beta of 2.08, suggesting that its share price is 108% more volatile than the S&P 500. Does the media refer more to CRON or TLRY? In the previous week, Tilray had 23 more articles in the media than Cronos Group. MarketBeat recorded 24 mentions for Tilray and 1 mentions for Cronos Group. Cronos Group's average media sentiment score of 1.44 beat Tilray's score of -0.05 indicating that Cronos Group is being referred to more favorably in the media. Company Overall Sentiment Cronos Group Positive Tilray Neutral SummaryTilray beats Cronos Group on 11 of the 18 factors compared between the two stocks. Get Tilray News Delivered to You Automatically Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLRY vs. The Competition Export to ExcelMetricTilrayMedicinals & botanicals IndustryStaples SectorNASDAQ ExchangeMarket Cap$1.08B$1.19B$15.26B$9.09BDividend YieldN/AN/A2.91%4.03%P/E Ratio-4.0034.6321.3517.33Price / Sales1.375.663.93134.95Price / CashN/A9.9616.8035.97Price / Book0.292.045.984.80Net Income-$244.98M-$53.10M$600.74M$224.91M7 Day Performance-2.44%-1.14%1.70%1.77%1 Month Performance-3.23%-3.86%-0.88%2.22%1 Year Performance-41.75%-8.56%6.14%20.67% Tilray Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLRYTilray2.5245 of 5 stars$1.20+1.7%$2.70+125.0%-41.7%$1.08B$788.94M-4.002,650Earnings ReportAnalyst RevisionCRONCronos Group2.7057 of 5 stars$1.96-1.0%$3.00+53.1%-1.0%$749.30M$111.23M-15.08450Short Interest ↓News CoveragePositive NewsUSNAUSANA Health Sciences4.5461 of 5 stars$34.21+1.0%$38.00+11.1%-29.0%$652.04M$861.97M12.091,900MNMDMind Medicine (MindMed)2.2953 of 5 stars$6.46-6.8%$26.75+314.1%+88.9%$473.73MN/A-2.8640Positive NewsGap DownCDXCChromaDex4.6424 of 5 stars$5.32+0.9%$8.00+50.4%+315.4%$406.36M$91.67M532.53120Analyst DowngradeShort Interest ↑BTMDbiote2.91 of 5 stars$5.57-1.4%$9.11+63.6%+21.8%$302.66M$193.06M21.42194News CoveragePositive NewsGap DownSNDLSNDL3.7204 of 5 stars$1.81-1.9%$3.25+80.1%+22.8%$299.67M$911.22M-5.822,516Positive NewsCGCCanopy Growth3.2353 of 5 stars$2.39-2.4%$3.50+46.4%-53.4%$260.37M$280.50M-0.483,150Short Interest ↓ACBAurora Cannabis0.2054 of 5 stars$3.98-3.6%N/A-13.2%$218.41M$296.99M-5.241,073Short Interest ↑MDWDMediWound1.516 of 5 stars$18.06+8.0%$27.50+52.3%+36.2%$194.80M$19.72M-6.2380FTLFFitLife Brands4.3728 of 5 stars$29.64-0.4%$40.00+35.0%+58.6%$136.29M$62.76M17.5420Short Interest ↓News CoveragePositive News Related Companies and Tools Related Companies CRON Competitors USNA Competitors MNMD Competitors CDXC Competitors BTMD Competitors SNDL Competitors CGC Competitors ACB Competitors MDWD Competitors FTLF Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TLRY) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredInvesting Tools You’ll Need for 2025Investing Tools You’ll Need for 2025 Charles Payne Shares His #1 Strategy for 2025 Unstoppable Prosperity | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tilray Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tilray With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
